Engage with U.S. payers in scientific dialogue about United Therapeutics products and pipeline assets. Attend meetings with market access account directors and MSLs. Present at Medicaid meetings. Serve as a resource for internal stakeholders and assist in the development of HEOR strategic and tactical plans. The role involves developing payer value propositions and healthcare economic information materials.

Leads key partnerships with academic institutions and network groups in guideline-enabling clinical trials supporting Signatera reimbursement and clinical adoption. This individual will leverage their scientific background in oncology alongside comprehensive commercial awareness of the precision oncology landscape and business acumen to bring MRD testing to oncology patients.